One-Year Outcome of Glycoprotein IIb/IIIa Inhibitor Therapy in Patients with Myocardial Infarction-Related Cardiogenic Shock

Background: We aimed to evaluate the effect of intravenous glycoprotein IIb/IIIa receptor inhibitors (GPIs) on in-hospital survival and mortality during and at the 1-year follow-up in patients undergoing percutaneous coronary intervention (PCI) for myocardial infarction (MI) complicated by cardiogen...

Descripción completa

Detalles Bibliográficos
Autores principales: Myrda, Krzysztof, Gąsior, Mariusz, Dudek, Dariusz, Nawrotek, Bartłomiej, Niedziela, Jacek, Wojakowski, Wojciech, Gierlotka, Marek, Grygier, Marek, Stępińska, Janina, Witkowski, Adam, Lesiak, Maciej, Legutko, Jacek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584341/
https://www.ncbi.nlm.nih.gov/pubmed/34768577
http://dx.doi.org/10.3390/jcm10215059

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584341/
https://www.ncbi.nlm.nih.gov/pubmed/34768577
http://dx.doi.org/10.3390/jcm10215059

Ejemplares similares